UCLA Researchers Perform Complete Genomic Sequencing of Brain Cancer Cell Line

Researchers at UCLA’s Jonsson Comprehensive Cancer Center have performed the first complete genomic sequencing of a brain cancer cell line. It’s a discovery that could facilitate personalized treatments based on the unique biological signature of an individual’s cancer and reveal new molecular targets for which more effective and less toxic drugs can be developed.

The study also may lead to new and better ways to monitor for brain cancer recurrence, allowing for much earlier diagnosis and treatment when the cancer returns. Clinicians could use the finding to develop a test to determine when the brain cancer has been killed, preventing overtreatment with harmful drugs that can later cause debilitating health problems. (source www.cancer.ucla.edu)